Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
Conclusions Sacubitril-valsartan may be a cost-effective treatment option depending on the willingness-to-pay threshold. Future investigations should incorporate real-world evidence with sacubitril-valsartan to further inform decision making.
Source: JACC: Heart Failure - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diovan | Enalapril | Heart | Heart Failure | Middle East Health | Study